New York Post | 28 Aug 2022
The Food and Drug Administration is expected to approve new COVID-19 booster shots this week — before the vaccines are tested on humans, according to a new report by the Wall Street Journal.
The new boosters are similar to the COVID vaccines currently available in the US with minor modifications that protect recipients from the latest version of the Omicron variant.
Instead of waiting for data from testing in humans, the agency will use data from trials in mice — as well as the real-world evidence of the safety of currently available COVID vaccines and test results from earlier iterations of boosters targeting older strains — to evaluate the newest boosters, FDA Commissioner Dr. Robert Califf said.
